Expression of amphiregulin predicts poor outcome in patients with pancreatic ductal adenocarcinoma

BACKGROUND: The validation of novel diagnostic, prognostic and predictive biomarkers in cancer is crucial for optimizing the choice and efficacy of personalized therapies. The aim of this study was to determine the epidermal growth factor receptor (EGFR), epidermal growth factor receptor variant III...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Diagn Pathol
Päätekijät: Wang, Li, Wu, Huanwen, Wang, Lili, Lu, Junliang, Duan, Huanli, Liu, Xuguang, Liang, Zhiyong
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2016
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4938900/
https://ncbi.nlm.nih.gov/pubmed/27391842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-016-0512-4
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia